about
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal P...
Read More
1.80
0.08
(4.65%)
105.5K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
BioVie Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..